Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Jun;97(24):e11113.
doi: 10.1097/MD.0000000000011113.

Primary small cell carcinoma of the ureter: Case report and review of the literature

Affiliations
Review

Primary small cell carcinoma of the ureter: Case report and review of the literature

Fabiola Farci et al. Medicine (Baltimore). 2018 Jun.

Abstract

Rationale: Primitive small cell carcinoma of the ureter is extremely rare, in this case report is meticulously described its aggressive clinical course and the pathological clues that help with the diagnosis. Also, a detailed table with the clinico-pathological features of analogous case reports in literature is provided.

Patient concerns: A 79-year-old female presented with gross hematuria and flank pain.

Diagnoses: Small cell carcinoma of the ureter. The surgical specimen showed a mixed histology of small cell carcinoma and transitional cell carcinoma; the common neuroendocrine markers (chromogranin A, synaptophysin, CD56) were positive, and vimentin and thyroid transcription factor 1 were negative. The patient had an advanced stage at presentation with regional nodes involvement (pT3N1).

Interventions: Segmental ureterectomy was performed but it was only possible to administer 1 cycle of platinum-based adjuvant chemotherapy due to the rapid decline of her clinical parameters.

Outcomes: The disease rapidly spread locally and metastasized.

Lesson: The clinicians must be aware of this aggressive tumor with silent clinical course and advanced stages at presentation.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
(A) Panoramic view of the ureteral tumor, hematoxylin–eosin stain (H&E). (B) The transitional cell carcinoma (red triangle) infiltrates the ureteral wall together with the small cell carcinoma (SCC) component with a clear lymphovascular invasion (black triangle) (H&E 10x). (C) The transitional cell carcinoma is intermixed with the SCC (H&E 20x). (D–F) The neuroendocrine markers are all positive in the SCC component (D: CD56, 10x; E: synaptophysin, 10x; F: chromogranin-A, 2x). (G) Ki-67 is remarkably high, especially in the SCC component of the tumor (2x). (H) TTF-1 immunohistochemistry is completely negative (2x). (I) The transitional cell carcinoma is CK7 positive (2x).

References

    1. Acosta AM, Kajdacsy-Balla A. Primary neuroendocrine tumors of the ureter: a short review. Arch Pathol Lab Med 2016;140:714–7. - PubMed
    1. Church DN, Bahl A. Clinical review: small cell carcinoma of the bladder. Cancer Treat Rev 2006;32:588–93. - PubMed
    1. Zhong W, Lin R, Zhang L, et al. Clinicopathologic characteristics, therapy and outcomes of patients with primary ureteral small cell carcinoma: a case series and systematic review of the literature. Onco Targets Ther 2017;10:4105–11. - PMC - PubMed
    1. Hensley PJ, Bhalodi AA, Gupta S. Primary upper urinary tract small cell carcinoma: a case series and literature review. J Endourol Case Rep 2017;3:165–8. - PMC - PubMed
    1. Alevizopoulos A, Yuen HS, Soumadri S, et al. Small cell carcinoma of the upper urinary tract: a case. report and review of existing cases. J Clin Case Rep 2016;6:811.